Edward Chu, MD
Interventional Cardiology · Newport News, VANPI 1487640272
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,291 of the $4,622 with a category attached, or 71.2%. 25 manufacturers reported payments, led by Abbott at 26.8% of the total. Reporting peaked in 2023 at $1,198 and has fallen 60.5% since, to $473 in 2025. That places this record below the midpoint for interventional cardiology clinicians in VA, where the typical reported total is $4,743.
Across 96 payments — averaging $48.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Abiomed$577
- Biotronik Inc.$518
- Atricure, Inc.$427
- Johnson & Johnson$236
- Boston Scientific$210
- plus $1K from 19 others
Across 35 payments — averaging $8871.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- American Regent$164K
- Boehringer Ingelheim Pharma GmbH & Co.kg$81K
- Boehringer Ingelheim International GmbH$65K
What the payments were for
- Travel & lodging$1,30728%
- Food & beverage$3,29171%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $1,237 |
| Abiomed | 9 | $577 |
| Biotronik Inc. | 5 | $518 |
| Atricure, Inc. | 8 | $427 |
| Johnson & Johnson | 14 | $236 |
| Boston Scientific | 7 | $210 |
| AstraZeneca | 3 | $207 |
| Pfizer | 9 | $182 |
| Livanova USA, Inc. | 2 | $161 |
| Biosense Webster, Inc. | 2 | $154 |
| Philips North America LLC | 2 | $131 |
| Medtronic | 1 | $123 |
| Getinge USA Sales, LLC | 1 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $68 |
| Novartis | 3 | $55 |
| Shockwave Medical, Inc | 2 | $46 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $37 |
| Teleflex LLC | 1 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
| Angiodynamics, Inc. | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$640
- Impella$365
- ENSITE PRECISION$360
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$312
- BioMonitor$145
- Carto 3$134
- BRILINTA$129
- LifeSPARC$128
- Micra$123
- LLD$116
- CARDIOHELP$102
How this compares
$4,622 in reported general payments places this provider in the 45th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 205 | $260,921 |
| EliquisApixaban | 216 | $246,509 |
| EntrestoSacubitril/Valsartan | 65 | $80,162 |
| MultaqDronedarone Hcl | 36 | $56,196 |
| FarxigaDapagliflozin Propanediol | 17 | $15,841 |
| Metoprolol Succinate | 549 | $6,616 |
| Ranolazine ErRanolazine | 38 | $4,892 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 162 | $3,761 |
| Prasugrel Hcl | 12 | $2,665 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 190 | $2,537 |
| Valsartan | 70 | $1,638 |
| Amlodipine Besylate | 198 | $1,238 |
| ClopidogrelClopidogrel Bisulfate | 134 | $1,091 |
| Atorvastatin Calcium | 155 | $1,091 |
| Carvedilol | 142 | $1,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $236 | $260,921205 claims |
| PfizerEliquis | $182 | $246,509216 claims |
| NovartisEntresto | $55 | $80,16265 claims |
| Sanofi-aventis U.S. LLCMultaq | $13 | $56,19636 claims |
| AstraZenecaFarxiga | $207 | $15,84117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Newport News
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
- Jason FoerstRoanoke$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.